Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update()

OBJECTIVE: To update the prevalence of atherosclerotic cardiovascular disease (ASCVD) in the United States (US) and re-evaluate lipid-lowering therapies (LLT) utilization and low-density lipoprotein cholesterol (LDL-C) goal attainment among ASCVD patients after proprotein convertase subtilisin/kexin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Jing, Sanchez, Robert, Chauhan, Ankita, Fazio, Sergio, Wong, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968014/
https://www.ncbi.nlm.nih.gov/pubmed/35368909
http://dx.doi.org/10.1016/j.ajpc.2022.100336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968014/
https://www.ncbi.nlm.nih.gov/pubmed/35368909
http://dx.doi.org/10.1016/j.ajpc.2022.100336

Ejemplares similares